Zobrazeno 1 - 10
of 1 342
pro vyhledávání: '"Paclitaxel resistance"'
Publikováno v:
Cancer Management and Research, Vol Volume 16, Pp 507-525 (2024)
Seunghee Bae,1 Sowon Bae,1 Hee Su Kim,1 Ye Jin Lim,1 Gyeongmi Kim,2 In-Chul Park,2 Kyeong A So,3 Tae Jin Kim,3 Jae Ho Lee1 1Department of Cosmetics Engineering, Konkuk University, Seoul, 05029, Republic of Korea; 2Division of Fusion Radiology Researc
Externí odkaz:
https://doaj.org/article/b7f2f9197dca4d0fa03a06c6cc0a8220
Autor:
Jiangchun Wu, Yong Wu, Tianyi Zhao, Xiangwei Wang, Qinhao Guo, Simin Wang, Siyu Chen, Xingzhu Ju, Jin Li, Xiaohua Wu, Zhong Zheng
Publikováno v:
MedComm, Vol 5, Iss 9, Pp n/a-n/a (2024)
Abstract Pyroptosis may play an important role in the resistance of ovarian cancer (OC) to chemotherapy. However, the mechanism by which pyroptosis modulation can attenuate chemotherapy resistance has not been comprehensively studied in OC. Here, we
Externí odkaz:
https://doaj.org/article/3958bd3ffe184144bca6c28482245525
Publikováno v:
Heliyon, Vol 10, Iss 17, Pp e36469- (2024)
Dysregulation of lncRNAs is a critical factor in the migration and invasion of tumors. Here our study reveals that lncRNA HIF1A-AS2 is highly expressed in breast cancer tissues and various TNBC cell lines. Moreover, we present compelling evidence sup
Externí odkaz:
https://doaj.org/article/5a18886ff0f64808b6e4084121b0b869
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-16 (2024)
Abstract Background Chemoresistance and immunosuppression are two major obstacles in the current anti-cancer treatments. This study investigates the involvements of a CCAAT enhancer binding protein delta (CEBPD)/vesicle associated membrane protein 3
Externí odkaz:
https://doaj.org/article/6847a7bb165b4b3084ffbfe4cd539ce4
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract In head and neck squamous cell carcinoma (HNSC), chemoresistance is a major reason for poor prognosis. Nevertheless, there is a lack of validated biomarkers to screen for patients for categorical chemotherapy. Fc gamma binding protein (FCGBP
Externí odkaz:
https://doaj.org/article/151a0bec6ceb4b1a9dda76daac68cf2b
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
AbstractBackground The chemotherapy resistance often leads to chemotherapy failure. This study aims to explore the molecular mechanism by which MUC1 regulates paclitaxel resistance in lung adenocarcinoma (LUAD), providing scientific basis for future
Externí odkaz:
https://doaj.org/article/ce78e1fb238942bca79b5cded5cf5199
Publikováno v:
Heliyon, Vol 10, Iss 13, Pp e33367- (2024)
Ovarian cancer represents a severe gynecological malignancy with a dire prognosis, underscoring the imperative need for dependable biomarkers that can accurately predict drug response and guide therapeutic choices. In this study, we harnessed online
Externí odkaz:
https://doaj.org/article/fcc23d9ab5154269a290c10bda9f0c73
Publikováno v:
Journal of Functional Foods, Vol 118, Iss , Pp 106245- (2024)
Breast cancer presents significant challenges in oncology, particularly basal-like breast cancer (BLBC), which shows resistance to paclitaxel treatment. This study examines the efficacy of halofuginone (HF), a compound from traditional Chinese medici
Externí odkaz:
https://doaj.org/article/deada9899b6a4fab95caa34925d0057a
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e31520- (2024)
Angiopoietin-like protein 3 (ANGPTL3) is key in ovarian cancer (OC) cell growth and metastasis, notably by enhancing natural killer cells' capacity for inducing cell toxicity and apoptosis. However, its role in influencing chemotherapy resistance in
Externí odkaz:
https://doaj.org/article/fb8e9b009adf4034bd64d5d377f8b916
Autor:
Cecilia Bergonzini, Alessandro Gregori, Tessa M. S. Hagens, Vera E. van der Noord, Bob van de Water, Annelien J. M. Zweemer, Bircan Coban, Mjriam Capula, Giulia Mantini, Asia Botto, Francesco Finamore, Ingrid Garajova, Liam A. McDonnell, Thomas Schmidt, Elisa Giovannetti, Erik H. J. Danen
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-16 (2024)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest types of cancer and the chemotherapies such as gemcitabine/nab-paclitaxel are confronted with intrinsic or acquired resistance. The aim of this study was to investiga
Externí odkaz:
https://doaj.org/article/178d9e5136a64abeb42daf0ec279d03d